• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.84% Nasdaq Down 2.94%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    170.85 Down 1.34(0.78%) Sep 1, 4:00PM EDT
    |After Hours : 170.85 0.00 (0.00%) Sep 1, 6:30PM EDT
    Add to Portfolio
    Prev Close:172.19
    Open:168.62
    Bid:166.02 x 100
    Ask:N/A
    1y Target Est:225.61
    Beta:1.20622
    Earnings Date:Oct 21 - Oct 26 (Est.)
    Day's Range:168.08 - 174.78
    52wk Range:150.06 - 208.88
    Volume:2,551,121
    Avg Vol (3m):1,840,170
    Market Cap:38.64B
    P/E (ttm):58.35
    EPS (ttm):2.93
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Headlines

    » More Headlines for ALXN

    Comparison

    Symbol% ChgMkt Cap
    ALXNDown 0.78%38.64B
    AMGNDown 2.85%111.81B
    BAXDown 3.17%20.31B

    Key Statistics

    Forward P/E (1 yr):28.62
    P/S (ttm):16.29
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :4.84
    Quarterly EPS Est (Sep-15) :1.01
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):2.10

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback